NEW YORK, July 1 (GenomeWeb News) - IT vendor CSP has sold the assets of its Scanalytics subsidiary to Becton Dickinson business Atto Bioscience for $453,000 in cash, the company said today.
Scanalytics, based in
The acquisition makes sense to BD. Most recently, BD Biosciences and Scanalytics signed an alliance to co-develop image-analysis software for BD Bioscience's automated microscopy platforms.
Dietrich Ruehlmann, BD Biosciences' product manager for imaging and analysis, told GenomeWeb News at the time that BD began the partnership with Scanalytics a few months ago with the goal of developing image-analysis platforms for BD Biosciences' CARV II Confocal Imager and Pathway Bioimager for high-content drug screening.